PROM1 and kidney disorder: Human adult kidney‐derived CD133+ cells have been shown to ameliorate injury following intravenous (IV) administration in mouse models of glycerol‐induced rhabdomyolysis 16, 19, 20 and adriamycin‐induced nephropathy 17.